Abstract
The aim of this paper was to study the effect of the granulate properties and tablet compression force on disintegrating force behavior in order to investigate the capability of the disintegrating force to characterize tablets that have the same composition but were manufactured in different conditions. Several tablets containing spironolactone in the external or internal granulated mixture of calcium carbonate and maize starch differing in particle size distribution, were prepared at 3 compression levels. The force developed by tablets during water uptake and disintegration was measured and plotted versus time. The curves obtained were analyzed by the Weibull equation in order to calculate the parameters characterizing the tablet disintegration kinetics. The disintegrating force time parameter, the maximum force developed, and the area under the curve were determined. In general, the reduction of time parameter value and/or the increase in maximum force developed corresponded to an acceleration in tablet disintegration. In addition, the area under the force curve increased in stronger tablets, monitoring in a sensitive way the tablet structural changes introduced by compression force. The results showed that the disintegrating force measurement can detect small changes in the structure of the tablet that cannot be discriminated by pharmacopoeia tests. The effect of manufacturing, in particular compression force, on tablet properties was quantified by the parameters of disintegrating force kinetics.
Keywords: disintegrating force, spironolactone, tablet, granulation, compression force
Full Text
The Full Text of this article is available as a PDF (373.7 KB).
References
- 1.Caramella C, Ferrari F, Bonferoni MC, Ronchi M. Disintegrants in solid dosage forms. Drug Dev Ind Pharm. 1990;16:2561–2577. doi: 10.3109/03639049009058547. [DOI] [Google Scholar]
- 2.Ferrari F, Bertoni M, Bonferoni MC, et al. Influence of porosity and formula solubility of disintegrant efficiency in tablet. STP Pharma Sciences. 1995;5:116–121. [Google Scholar]
- 3.Vadas EB, Down GRB, Miller RA. Effect of compressional force on tablets containing cellulosic disintegrators, I: dimensionless disintegration values. J Pharm Sci. 1984;73:781–783. doi: 10.1002/jps.2600730618. [DOI] [PubMed] [Google Scholar]
- 4.Caramella C, Colombo P, Conte U, Gazzaniga A, Manna A. The role of swelling in the disintegration process. International Journal of Pharmaceutical Technology & Product Manufacture. 1984;5:1–5. [Google Scholar]
- 5.Colombo P, Conte U, Caramella C, Geddo M, Manna A. Disintegrating force as a new formulation parameter. J Pharm Sci. 1984;73:701–705. doi: 10.1002/jps.2600730531. [DOI] [PubMed] [Google Scholar]
- 6.Catellani PL, Predella P, Bellotti A, Colombo P. Tablet water uptake and disintegration force measurements. Int J Pharm. 1989;51:63–66. doi: 10.1016/0378-5173(89)90075-6. [DOI] [Google Scholar]
- 7.Massimo G, Catellani PL, Santi P, et al. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics. Pharm Dev Technol. 2000;5:163–169. doi: 10.1081/PDT-100100531. [DOI] [PubMed] [Google Scholar]
- 8.Badwan AA, Nabulsi LN, Saleh MR, Arafat TA. Leveling off the effect of particle size on dissolution in spironolactone tablets. Congr Int Technol Pharm 5th. 1989;5:418–426. [Google Scholar]
- 9.ElShabouri MH. Nanoparticles for improving the dissolution and oral bioavailability of spironolactone, a poorly-soluble drug. STP Pharma Sciences. 2002;12:97–101. [Google Scholar]
- 10.Langenbucher L. Parametric representation of dissolution-rate curves by the RRSBW distribution. Die Pharmazeutische Industie. 1976;38:472–477. [Google Scholar]
- 11.Rodriguez F, Arama E, Maghi M, Paulin T, Ruffiac R. Application of the Weibull function to the study of in vivo/in vitro correlation. J Pharm Belg. 1990;45(3):173–183. [PubMed] [Google Scholar]